A Phase 1 Open -Label Multicenter Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Calcipotriene Foam, 0.005% Applied Under Maximal Use Conditions in Adolescent Subjects with Plaque Psoriasis
Adelaide Hebert, Debbie Glaab, Rhonda Schreiber
Abstract not available.
Disclosures: Study sponsored by Mayne Pharma.
Abstract - 112 Poster PDF - 26
- There are currently no refbacks.